NCT06581484 Improving Congenital Heart Disease Care
| NCT ID | NCT06581484 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Congenital Heart Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2024-09-05 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2024-09-05 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The theory-informed digital health intervention, called as "Empower My Congenital Health (EmpowerMyCH)" aims to activate and engage ACHD patients in building confidence toward navigating the adult healthcare system. This tool is built after incorporating the theories of behavior change, gathering inputs from target patients in all stages of its design and implementation. The key features of the tool include a digital medical passport, updated congenital information, community support, and patient stories and advice. The investigators aim to test the acceptability, feasibility, efficacy, and effectiveness of the intervention.
Eligibility Criteria
Inclusion Criteria: * have congenital heart disease * 18 years or older * can sign the informed consent Exclusion Criteria: * developmentally delayed * unable to consent
Contact & Investigator
Anushree Agarwal, MBBS, MAS
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06581484 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Congenital Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06581484 currently recruiting?
Yes, NCT06581484 is actively recruiting participants. Contact the research team at anu.agarwal2@ucsf.edu for enrollment information.
Where is the NCT06581484 trial being conducted?
This trial is being conducted at San Francisco, United States.
Who is sponsoring the NCT06581484 clinical trial?
NCT06581484 is sponsored by University of California, San Francisco. The principal investigator is Anushree Agarwal, MBBS, MAS at University of California, San Francisco. The trial plans to enroll 1,000 participants.